This webinar will be hosted live and available on-demand

Tuesday, June 11, 2024
11:00 AM- 12:00 PM ET

Scientists use biomarkers for numerous applications including detecting abnormal processes, monitoring disease progression, and assessing drug efficacy. However, the screening assays employed by researchers to discover protein-based biomarkers can be constrained by their capacity to measure a large number of analytes simultaneously and accommodate different sample types.

In this webinar brought to you by The Life Science Business of Merck KGaA, Darmstadt, Germany and Luminex, Anthony Saporita and Stephen Angeloni will highlight the configurable MILLIPLEX® PLEXpedition panel which allows scientists to simultaneously screen up to 115 analytes, such as chemokines, growth factors, and matrix metalloproteinases, in a single experiment using the Luminex® xMAP INTELLIFLEX® System, a robust and versatile method for multiplexed biomarker analysis.

Topics to be covered 

  • The advantages of the MILLIPLEX® PLEXpedition screening assay
  • Distinguishing between MILLIPLEX® screening and qualified assays 
  • The unique and familiar features of the xMAP INTELLIFLEX® system
Anthony Saporita, PhD

Anthony Saporita, PhD
R&D Manager
The Life Science business of Merck KGaA, Darmstadt, Germany

Stephen Angeloni, PhD

Stephen Angeloni, PhD
Senior Field Application Scientist
Luminex

Sponsored by